BDX Q2 2025 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.3B+4.5% YoY

Gross Profit

$2.3B42.8% margin

Operating Income

$546M10.4% margin

Net Income

$308M5.8% margin

EPS (Diluted)

$1.07

QoQ Revenue Growth

+2.0%

Cash Flow

Operating Cash Flow

$164M

Free Cash Flow

$35M

Stock-Based Comp.

$149M

Balance Sheet

Total Assets

$54.5B

Total Liabilities

$29.2B

Stockholders' Equity

$25.2B

Cash & Equivalents

$667M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.3B	$5.0B	+4.5%
Gross Profit	$2.3B	$2.3B	-2.0%
Operating Income	$546M	$734M	-25.6%
Net Income	$308M	$537M	-42.6%

Revenue Segments

Medical

$2.8B52%

Interventional

$1.3B24%

Life Sciences

$1.2B24%

Geographic Segments

UNITED STATES

$3.1B59%

Non-US

$2.2B41%